Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
159.45
+11.08 (7.47%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Inspire Medical Systems Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Inspire Medical Systems stock have an average target of 220.27, with a low estimate of 175 and a high estimate of 255. The average target predicts an increase of 38.14% from the current stock price of 159.45.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Inspire Medical Systems stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $190 → $175 | Hold | Maintains | $190 → $175 | +9.75% | Apr 21, 2025 |
| Keybanc | Keybanc | Buy Maintains $234 → $216 | Buy | Maintains | $234 → $216 | +35.47% | Apr 21, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $260 → $215 | Buy | Maintains | $260 → $215 | +34.84% | Apr 15, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $250 → $235 | Strong Buy | Maintains | $250 → $235 | +47.38% | Feb 11, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $260 | Buy | Reiterates | $260 | +63.06% | Feb 11, 2025 |
Financial Forecast
Revenue This Year
968.61M
from 802.80M
Increased by 20.65%
Revenue Next Year
1.14B
from 968.61M
Increased by 17.49%
EPS This Year
2.21
from 1.75
Increased by 26.31%
EPS Next Year
3.26
from 2.21
Increased by 47.46%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.0B | 1.2B | 1.4B | ||
| Avg | 968.6M | 1.1B | 1.3B | ||
| Low | 921.2M | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.3% | 24.6% | 25.7% | ||
| Avg | 20.7% | 17.5% | 16.4% | ||
| Low | 14.7% | 10.0% | 6.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.34 | 4.67 | 6.53 | ||
| Avg | 2.21 | 3.26 | 4.70 | ||
| Low | 2.06 | 2.65 | 3.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 33.8% | 111.4% | 100.4% | ||
| Avg | 26.3% | 47.5% | 44.1% | ||
| Low | 17.6% | 19.7% | 16.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.